ahlam1399
09-23-2015, 06:18 PM
Amgen, Allergan say Avastin copycat succeeds in lung cancer study
(Reuters) - Amgen Inc and Allergan Plc said their drug candidate for lung cancer was found as effective as Roche AG's Avastin in preventing disease progression and improving survival, in a late-stage study.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a19b54e/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=lOzSUjqBUiY:X8ghVe8KLso:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lOzSUjqBUiY:X8ghVe8KLso:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=lOzSUjqBUiY:X8ghVe8KLso:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lOzSUjqBUiY:X8ghVe8KLso:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=lOzSUjqBUiY:X8ghVe8KLso:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/lOzSUjqBUiY
(Reuters) - Amgen Inc and Allergan Plc said their drug candidate for lung cancer was found as effective as Roche AG's Avastin in preventing disease progression and improving survival, in a late-stage study.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a19b54e/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=lOzSUjqBUiY:X8ghVe8KLso:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lOzSUjqBUiY:X8ghVe8KLso:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=lOzSUjqBUiY:X8ghVe8KLso:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lOzSUjqBUiY:X8ghVe8KLso:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=lOzSUjqBUiY:X8ghVe8KLso:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/lOzSUjqBUiY